Review
Aug 2026
Precision Warfare in Solid Tumors: Molecular Mechanisms and Emerging Frontiers of Antibody-Drug Conjugates.
Continual advances in molecular engineering and precision biomarker strategies are redefining ADCs as versatile platforms for precision oncology and may enable broader, potentially tumor-agnostic, applications in solid tumors.
H. P. Luqmana, A. Ashariati, M. Savitri et al.
· Immunological Investigations · 0 citations